Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 9:10:180.
doi: 10.4103/ijpvm.IJPVM_66_18. eCollection 2019.

Evaluation of the Protective Effect of Cystone Against Cisplatin-induced Nephrotoxicity in Patients with Cancer: A Pilot Study

Mohammad Reza Tamadon  1 , Samaneh Tirom  1 , Farahnaz Ghahremanfard  1 , Azar Baradaran  2 , Raheb Ghorbani  3
Affiliations

Evaluation of the Protective Effect of Cystone Against Cisplatin-induced Nephrotoxicity in Patients with Cancer: A Pilot Study

Mohammad Reza Tamadon et al. Int J Prev Med. .

Abstract

Introduction: Cisplatin is a widely used anti-cancer drug that is commonly administered for the treatment of various cancers. However, nephrotoxicity is the most important side effect of this drug which limits its use. This study aimed to investigate the protective effect of Cystone against nephrotoxicity induced by Cisplatin in patients with cancer.

Methods: This pilot clinical trial study was conducted on 43 cancer patients treated with Cisplatin (75 mg/m2 for a period of six months). The subjects were divided into treatment group (receiving Cystone, two per 8 hours; n = 21) and control group (n = 22). The two groups were compared with each other in terms of demographic and laboratory variables.

Results: In the intervention group receiving Cystone, serum creatinine-based GFR level (P = 0.453) and 24-hour urine creatinine-based GFR level (P = 0.397) did not change significantly during the studied period, but in the control group, serum creatinine-based GFR level (P = 0.013) and 24-hour urine creatinine-based GFR level (P = 0.016) significantly changed. Serum creatinine-based GFR level increased by 2.3 units in the intervention group and 10.5 units in the control group (P = 0.005) in the six months of the study. At the end of the sixth month, 24-hour urine creatinine-based GFR level increased by 2.2 units in the intervention group and 0.8 unit in the control group (P = 0.008).

Conclusions: The use of Cystone resulted in more stable kidney function indices in the intervention group, as compared with the control group. Therefore, Cystone seems to have a protective effect against nephrotoxicity induced by Cisplatin in cancer patients.

Keywords: Cisplatin; cystone; neoplasm; nephrotoxicity.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Mohamed R, Viswanatha GL. Cystone, a well-known formulation improves renal function in rats with acute renal failure induced by glycerol intoxication. Iran J Pharmacol Ther. 2012;11:40–4.
    1. Hasanvand A, Mir S, Mohammadrezaei Khorramabadi R, Darabi S. Ameliorative effect of ferulic acid on gentamicin-induced nephrotoxicity in a rat model; role of antioxidant effects. J Renal Inj Prev. 2018;7:73–7.
    1. Tamadon MR, Ardalan MR, Nasri H. World Kidney Day 2013; acute renal injury; a global health warning. J Parathyr Dis. 2013;1:27–8.
    1. Mohammadi A, Ahmadizadeh M. Effects of antioxidants on xenobiotics-induced nephrotoxicity. J Renal Inj Prev. 2018;7:56–7.
    1. Tan RZ, Liu J, Zhang YY, Wang HL, Li JC, Liu YH, et al. Curcumin relieved cisplatin-induced kidney inflammation through inhibiting Mincle-maintained M1 macrophage phenotype. Phytomedicine. 2019;52:284–94. - PubMed